Lifecore Biomedical, Inc.

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.












The submission of this form does not create an attorney-client relationship.

Investigation Details

Lifecore announced on March 20, 2024, that its Board of Directors had concluded its review of strategic alternatives, in which it “unanimously concluded that the best way to maximize value for stockholders at this time is to continue executing on the Company’s standalone strategic plan.” The Company also announced a leadership transition by naming a new CEO. Following this news, shares of Lifecore dropped over 35% in morning trading on the same day.